Tessa Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) (NCT04268706) | Tessa Therapeutics | 2021-02-01 |
Track Tessa Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.